Posted: 25 May
The role
Healthcare M&A in Europe is won by advisors who understand the regulatory, commercial, and clinical dimensions of a business — not just the financials. After 20+ years in the sector, you do.
ONEtoONE is a global network of 120+ independent M&A advisors in 55 countries. Our Senior Industry Advisors in healthcare co-advise on transactions where sector credibility is the critical differentiator — from pharma and biotech to medtech, diagnostics, and healthcare services.
What you get
- Competitive revenue share on mandates you originate or where your healthcare expertise drives the process
- Active deal flow across UK and European healthcare: pharma, medtech, biotech, digital health, healthcare services
- Institutional brand: operate as a Senior Advisor of a recognised global investment banking platform
- 200+ advisors in 55 countries — connecting healthcare companies with global strategic buyers, PE sponsors, and trade buyers
- Full execution support: analyst team, sector databases, CIMs, and pitch materials provided
Who you are
- Former CEO, MD, CMO, or CFO of a UK or European healthcare, pharma, or medtech company — 20+ years in the sector
- Deep personal network within the UK and European healthcare executive, PE, and investor community
- Experience with acquisitions, divestments, licensing deals, or investor processes from the operator's side
- Currently independent, on advisory boards, or exploring a portfolio career
The business owner in healthcare trusts advisors who have navigated the same regulatory and commercial environments. ONEtoONE Senior Industry Advisors are exactly that — backed by a global M&A platform.
Just to set the right expectations: this is a commercial partnership model — no fixed salary — with compensation linked to mandate participation and deal success.
